BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 1733713)

  • 1. Effects of hypothyroidism on hypothalamic release of thyrotropin-releasing hormone in rats.
    Rondeel JM; de Greef WJ; Klootwijk W; Visser TJ
    Endocrinology; 1992 Feb; 130(2):651-6. PubMed ID: 1733713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid vascular conductance: differential effects of elevated plasma thyrotropin (TSH) induced by treatment with thioamides or TSH-releasing hormone.
    Connors JM; Huffman LJ; Michalkiewicz M; Chang BS; Dey RD; Hedge GA
    Endocrinology; 1991 Jul; 129(1):117-25. PubMed ID: 1905224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thyroid status on release of hypothalamic thyrotropin-releasing hormone.
    Rondeel JM; de Greef WJ; Visser TJ
    Horm Metab Res Suppl; 1990; 23():1-4. PubMed ID: 2120121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-releasing hormone stimulates growth hormone release from the anterior pituitary of hypothyroid rats in vitro.
    Szabo M; Stachura ME; Paleologos N; Bybee DE; Frohman LA
    Endocrinology; 1984 Apr; 114(4):1344-51. PubMed ID: 6423373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.
    Geffner DL; Azukizawa M; Hershman JM
    J Clin Invest; 1975 Feb; 55(2):224-9. PubMed ID: 805160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.
    Saberi M; Sterling FH; Utiger RD
    J Clin Invest; 1975 Feb; 55(2):218-23. PubMed ID: 1173242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of the thyroid hormone negative feedback regulation of TSH secretion in spontaneously hypertensive rats.
    Bruhn TO; Jackson IM
    Regul Pept; 1992 Apr; 38(3):221-30. PubMed ID: 1589596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood.
    Rondeel JM; de Greef WJ; van der Schoot P; Karels B; Klootwijk W; Visser TJ
    Endocrinology; 1988 Jul; 123(1):523-7. PubMed ID: 3133200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus.
    Diano S; Naftolin F; Goglia F; Horvath TL
    Endocrinology; 1998 Jun; 139(6):2879-84. PubMed ID: 9607797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone regulation of hypothalamic immunoreactive thyrotropin.
    DeVito WJ
    Endocrinology; 1989 Sep; 125(3):1219-23. PubMed ID: 2759023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin-releasing hormone and thyroid hormone interactions on thyrotropin secretion in the rat: lack of inhibiting effects of small doses of triiodo-L-thyronine in the hypothyroid rat.
    García MD; Escobar del Rey F; Morreale de Escobar G
    Endocrinology; 1976 Jan; 98(1):203-13. PubMed ID: 813987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma 3,5,3'-triiodothyronine sulfate in rats with inhibited type I iodothyronine deiodinase activity, as measured by radioimmunoassay.
    Rooda SJ; Kaptein E; Rutgers M; Visser TJ
    Endocrinology; 1989 Feb; 124(2):740-5. PubMed ID: 2912698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylmercaptoimidazole (MMI), propylthiouracil (PTU), potassium perchlorate (KClO4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat.
    Männistö PT; Ranta T; Leppäluoto J
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):271-81. PubMed ID: 111448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of thyroid hormones in vitro and in vivo on hypothalamic neurotensin release and content.
    Sheppard MC; Shennan KI
    Endocrinology; 1983 Jun; 112(6):1996-8. PubMed ID: 6406207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Iopanoic acid on the pituitary-thyroid axis: time sequence of changes in serum iodothyronines, thyrotropin, and prolactin concentrations and responses to thyroid hormones.
    Suzuki H; Noguchi K; Nakahata M; Nakagawa S; Kadena N
    J Clin Endocrinol Metab; 1981 Oct; 53(4):779-83. PubMed ID: 6793610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of chronic treatment with iopanoic acid on thyroxine metabolism in the newborn rat.
    Redjem M; Verdaguer M; Vigouroux E
    Horm Metab Res; 1990 Jun; 22(6):329-33. PubMed ID: 2379915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that thyroxine inhibits either basal or TRH-induced TSH secretion only after conversion to triiodothyronine.
    Maruta S; Greer MA
    Proc Soc Exp Biol Med; 1988 Apr; 187(4):391-7. PubMed ID: 3127831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity of the thyrotroph to thyrotropin-releasing hormones in rats with hypothalamic hypothyroidism.
    Aizawa T; Kobayashi M; Komiya I; Hiramatsu K; Sato A; Yamada T
    Endocrinology; 1984 Jan; 114(1):8-13. PubMed ID: 6418526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitatory role of serotonin (5-HT) in the control of thyrotropin releasing hormone/thyrotropin (TRH/TSH) secretion in rats.
    Silva JD; Nunes MT
    Braz J Med Biol Res; 1996 May; 29(5):677-83. PubMed ID: 9033822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine treatment differently affects releasable thyrotropin-releasing hormone (TRH) pools in the hypothalamic paraventricular nucleus (PVN) and the median eminence (ME).
    Alexander K; Nikodémová M; Kucerová J; Strbák V
    Cell Mol Neurobiol; 2005 Jun; 25(3-4):681-95. PubMed ID: 16075386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.